Prasugrel forhindrer blodpladerne i at aggregere ved at forhindre stoffet ADP i at binde sig til en såkaldt receptor på blodpladernes overflader.
Prasugrel stops the platelets aggregating by blocking a substance called ADP from binding to a receptor on their surface.